Rule 45 Material Movement: ITC-04 for Pharma Loan-Licensees

A Mumbai-registered pharma brand-owner in the pattern of Ipca Laboratories — running a Chapter 29 antibiotic formulation portfolio through a three-loan-licensee network at Baddi in Himachal Pradesh, Silvassa in the Dadra and Nagar Haveli UT, and Sikkim — closes its Q1 FY 2026-27 (April to June 2026) job-work compliance cycle on 25 July 2026 with a Form GST ITC-04 filing that covers 148 dispatch challans across the three loan-licensees, a Q1 aggregate API dispatch value of Rs 22.4 crore, 142 return-of-goods challans (Rs 21.6 crore) from the same loan-licensees, and 6 challans (Rs 0.8 crore) still pending return at quarter-end — with the oldest of the six approaching a 9-month age against the Section 143(1)(a) 12-month return deadline. This is Rule 45 material movement ITC-04 pharma loan-licensee compliance at operating scale, and the discipline that separates a clean quarterly filing from a Rule 45(4) deemed-supply provision on the year-end books is a per-challan material movement register that ties the brand-owner’s ERP dispatch feed to the loan-licensee’s return-challan intake, a proactive 12-month aging monitor with escalation triggers at 9, 10 and 11 months, a Form GST ITC-04 draft that correctly populates Tables 4, 5A, 5B and 6, and a portal-vs-books tie-out that catches any variance before it lands as a Section 65 audit finding.

Quick reference

The reconciliation in one paragraph

A pharma brand-owner that dispatches active pharmaceutical ingredient from its Mumbai godown to a third-party manufacturer at Baddi, Silvassa or Sikkim under a loan-licensing arrangement is running a Section 143 job-work transaction. Under Section 143 of the Central Goods and Services Tax Act 2017, the brand-owner (the principal) sends inputs to the loan-licensee (the job-worker) without payment of tax — the underlying dispatch is not treated as a taxable event so long as the goods return to the principal within one year of the dispatch date. Rule 45 of the CGST Rules 2017 gives the operational mechanic: every dispatch must carry a delivery challan with the Rule 55 mandatory fields, the movement must be recorded in a per-challan register at both ends, and the aggregate quarter’s movement — dispatch to the job-worker and receipt back from the job-worker — must be filed on Form GST ITC-04 by the 25th day of the month following quarter-end. Rule 45(4) is the enforcement teeth: any input dispatched but not received back within the one-year window is deemed to be a supply from the original dispatch date, the challan is treated as an invoice, and the principal must pay the GST on the deemed-supply value plus interest under Section 50 at 18 percent per annum from the original dispatch date. Separately, the loan-licensee raises its own HSN 9988 job-work service invoice at 12 percent (IGST for inter-state loan-licensing) for the conversion charge — a distinct GST-liable outward supply that creates ITC in the brand-owner’s electronic credit ledger against the input-service leg.

What the scenario looks like in India — the illustrative persona

The Indian pharma industry’s loan-licensee model is the dominant contract-manufacturing paradigm for tablet, capsule, injectable and topical formulations. A brand-owner pharma company that holds the drug licence for a specific dosage form in Form 25 or Form 28 with the state Food and Drug Administration routes physical manufacture through a third-party manufacturer that holds the corresponding loan-licence in Form 25A or Form 28A for the specific dosage form and the specific manufacturing site. The brand-owner supplies the active pharmaceutical ingredient (typically Chapter 29 organic chemicals — 2941 for antibiotics — or Chapter 30 bulk drug preparations under 3003); the loan-licensee supplies its formulation line, its skilled operators, its quality-control laboratory, and its manufacturing licence for the site; the finished formulation returns to the brand-owner for pack-house and market release.

Loan-licensing manufacturing geography clusters at the excise-legacy manufacturing hubs. Baddi in Himachal Pradesh is the single largest concentration of third-party pharma manufacturing capacity in India, built up under the erstwhile area-based excise exemption regime that ran up to 2010 — the plants built under that regime remain in operation as loan-licensees under multiple brand-owner arrangements. Silvassa in the Dadra and Nagar Haveli UT hosts a smaller but active third-party cluster. Sikkim carries the Section 80-IE income-tax deduction legacy cluster with a concentration of formulation capacity. Roorkee in Uttarakhand, Guwahati in Assam and Solan-Nalagarh in Himachal complete the geography. Third-party manufacturers active in the pharma loan-licensee segment include Wockhardt, Cachet Pharma, Zim Laboratories, Kilitch Drugs, JB Chemicals & Pharmaceuticals, and Sical Chemicals — each holding loan-licences for specific dosage forms and serving multiple brand-owner principals through concurrent job-work arrangements.

For the reconciliation this article walks through, the reference persona is a Mumbai-registered brand-owner at the scale of Ipca Laboratories running a Chapter 29 antibiotic formulation portfolio through three loan-licensees at Baddi (Himachal Pradesh), Silvassa (Dadra and Nagar Haveli UT) and Sikkim. The Q1 FY 2026-27 dispatch pattern runs at approximately 148 challans aggregate across the three loan-licensees over the April to June 2026 quarter, at a per-challan quantity of the order of 4 to 6 tonnes of Chapter 29 API and an illustrative per-challan value of Rs 8 to 15 lakh. The three loan-licensees are three distinct third-party manufacturing entities with three distinct state GSTINs — the brand-owner’s Mumbai GSTIN dispatches inter-state to each, and the return of finished formulation flows back inter-state from each. The brand-owner’s compliance calendar treats the quarterly ITC-04 filing as a hard 25th-of-following-month deadline and the 12-month aging monitor as a continuous background control.

The regulatory overlay — Section 143 CGST, Rule 45, Form GST ITC-04, and the deemed-supply enforcement

Four regulatory anchors govern the brand-owner’s job-work compliance cycle across the three-loan-licensee network, and each maps to a specific reconciliation surface.

Section 143 of the Central Goods and Services Tax Act 2017 is the enabling provision. Section 143(1) permits a registered person (the principal) to send any inputs or capital goods to a job-worker for job work without payment of tax and, subject to conditions, from there to another job-worker. Section 143(1)(a) sets the one-year time limit for return of inputs to any of the principal’s places of business, extendable by an additional one year with jurisdictional Commissioner approval. Section 143(1)(b) sets the three-year time limit for return of capital goods. Section 143(3) is the deemed-supply teeth for inputs — if the inputs are not received back within the specified period, they shall be deemed to have been supplied by the principal to the job-worker on the day the inputs were sent out, and the principal is liable to pay GST on that deemed supply along with interest under Section 50 at 18 percent per annum. Section 143(4) applies the same treatment to capital goods with the three-year window.

Rule 45 of the CGST Rules 2017 gives the operational mechanic. Rule 45(1) requires that inputs and capital goods sent to a job-worker be sent under the cover of a delivery challan issued by the principal, containing the Rule 55 mandatory fields — challan number, date, consigner name/address/GSTIN, consignee name/address/GSTIN (the job-worker), HSN code, description of goods, quantity, taxable value, tax rate, and place of supply for interstate movement. Rule 45(2) permits the goods to be sent directly from the supplier’s place of business to the job-worker (the drop-ship-to-job-worker scenario, useful where a brand-owner sources API from its own supplier and routes it directly to the loan-licensee without intermediate handling at the brand-owner’s godown). Rule 45(3) mandates that the details of challans in respect of goods dispatched to and received from a job-worker during a quarter be furnished on Form GST ITC-04 by the 25th day of the month following the quarter. Rule 45(4) is the deemed-supply mechanic — where the inputs or capital goods are not received back within the time specified in Section 143, the challan issued under Rule 45(1) shall be treated as an invoice for the deemed supply, and the GST liability plus Section 50 interest is computed and paid through the principal’s next GSTR-3B.

Form GST ITC-04 is the quarterly electronic return filed on the GST portal. Table 4 records goods dispatched to job-worker during the quarter at challan level. Table 5A records goods received back from the same job-worker to whom the goods were originally sent — the standard round-trip case where the loan-licensee finishes the formulation and returns it under its own return challan. Table 5B records goods received back from a job-worker other than the one to whom the goods were originally sent — the inter-job-worker transfer case, permitted under Section 143(1) where the principal has declared the additional job-worker’s place of business as an additional place of business, or the additional job-worker itself is GST-registered. Table 6 records goods that have been deemed as supplied under Rule 45(4) because the 12-month (or three-year for capital goods) window has expired without return.

HSN 9988 covers manufacturing services on physical inputs owned by others — the loan-licensee’s core outward supply to the brand-owner. Pharmaceutical job-work under HSN 9988 attracts 12 percent GST (CGST 6 percent plus SGST 6 percent for intra-state, IGST 12 percent for inter-state). A Mumbai-registered brand-owner engaging a Baddi (Himachal Pradesh), Silvassa (Dadra and Nagar Haveli UT) or Sikkim loan-licensee is inter-state — the loan-licensee raises an IGST-12-percent invoice on the job-work service charge. The dispatch of API from the brand-owner and the return of finished formulation are not supplies under Section 143 and do not create GST liability on either side, provided the Rule 45 challan and ITC-04 return discipline is maintained. The loan-licensee’s own turnover on its HSN 9988 job-work service is its own outward supply and feeds its own GSTR-1 and GSTR-3B; the loan-licensee’s Section 22 GST registration is separate from the brand-owner’s registration.

A worked example — Q1 FY 2026-27 close across three loan-licensees

Illustrative — the following figures represent the operating pattern of a Mumbai-registered brand-owner pharma company running a Chapter 29 antibiotic loan-licensee network across three third-party manufacturing hubs at the scale that Tier 2 listed Indian pharma companies operate. Public disclosures do not reveal per-quarter loan-licensee-network dispatch quantum in the granularity below; cross-verify against your own Rule 45 challan register and ITC-04 filing history before action.

The Q1 FY 2026-27 (April to June 2026) material movement position across the three-loan-licensee network, aggregated for the ITC-04 filing due on 25 July 2026:

The aging monitor on the 6 pending challans at quarter-end triggers a proactive follow-up: the oldest Baddi challan at ~9-month age has 3 months of return window remaining before the Section 143(1)(a) 12-month deadline lapses; the Silvassa oldest at ~8-month age has 4 months remaining; the Sikkim oldest at ~7-month age has 5 months remaining. The Q1 ITC-04 filing on 25 July 2026 shows Table 4 dispatch count of 148 and Table 5A return count of 142; the 6 pending challans do not enter any Table for Q1 (they remain in the brand-owner’s Rule 45 register as work-in-process at the loan-licensee). Table 5B is Nil for Q1 because no inter-job-worker transfer scenario ran during the quarter. Table 6 is Nil for Q1 because no challan has crossed the 12-month deadline during the quarter.

The Q2 forecast, however, carries a specific risk — the Baddi oldest pending challan will hit its 12-month deadline in mid-Q2 (around September 2026). If the loan-licensee does not return the finished formulation by that date, the challan enters Table 6 of the Q2 ITC-04 filing (due 25 October 2026) as deemed supply, the taxable value of Rs 12 lakh (illustrative — the largest of the 6 pending challans) enters GST liability at 5 percent (Chapter 29 antibiotic IGST rate for inter-state deemed supply) — Rs 60,000 GST — and Section 50 interest at 18 percent per annum on the Rs 60,000 for the ~12-month period from original dispatch to the deemed-supply date runs to approximately Rs 10,800. The brand-owner’s compliance team makes the strategic call: pursue the return aggressively through the loan-licensee QA and dispatch channels in Q2, or provision the deemed-supply GST-plus-interest in the Q2 books and pay through the Q2 GSTR-3B. The choice is driven by the underlying commercial reality — is the API converted and awaiting quality-control clearance (return likely), or is it stuck in production due to a formulation-line issue (return unlikely by deadline).

On the loan-licensee HSN 9988 job-work service invoice side, the Q1 aggregate of Rs 2.5 crore in job-work service across the three loan-licensees carries IGST 12 percent of Rs 30 lakh. The brand-owner’s GSTR-2B for Q1 auto-populates the ITC on the three loan-licensee invoices; the ITC flows to the brand-owner’s Maharashtra electronic credit ledger as input-service ITC on the finished formulation cost. This ITC does not feed the Net ITC in any Rule 89(5) inverted-duty refund the brand-owner might file on its Chapter 30 formulation output at 5 percent (input-service ITC is excluded from Net ITC in the Rule 89(5) inverted-duty refund pharma formulations complete guide); it is a distinct ITC pool used against domestic GST payable on the brand-owner’s own outward taxable supplies.

Common reconciliation breakages

Five breakages recur across pharma brand-owners running the Rule 45 material movement plus quarterly ITC-04 filing cycle, and each maps to a specific control failure that a Section 65 GST audit or a Rule 45(4) deemed-supply reassessment will surface.

• Rule 55 challan-field gap on dispatch. The most common failure at the dispatch end is a delivery challan that omits one or more of the Rule 55 mandatory fields — most often the place of supply for interstate movement, or the tax rate line (where the challan template defaulted from a domestic-supply template and omitted the tax-rate field). A defective challan invalidates the Rule 45 movement itself; the GST officer at scrutiny can treat the dispatch as a taxable supply from the original date. Reconciliation discipline: the ERP-driven challan generation must be templated to always populate every Rule 55 field, and a pre-dispatch validation step must block any challan with a missing mandatory field before physical dispatch clears the godown.

• Table 4 to Table 5A/5B mismatch — inter-job-worker return misfiled. A subset of the six loan-licensees serving a brand-owner may operate as an additional-place-of-business under a primary loan-licensee’s declaration, or may hold their own separate GST registration and act as a downstream converter. When the return of finished formulation comes back via a loan-licensee different from the original dispatch destination, the return challan must file in Table 5B, not Table 5A. Brand-owners that default all returns to Table 5A regardless of the actual return-source loan-licensee create a portal-vs-books tie-out variance; the ITC-04 Table 5A total exceeds what the same-job-worker-return register supports, and a proper officer scrutiny query surfaces at the quarter’s audit.

• 12-month aging blind spot — no proactive monitor. Brand-owners that treat the Rule 45 register as a static log — populated at dispatch and consulted only at the quarterly ITC-04 filing step — miss the proactive follow-up window. A challan that sits at 11 months and 20 days age at the quarterly close will not enter Table 6 for that quarter’s ITC-04 (it has not yet crossed the deadline), but by the time the next quarter’s ITC-04 is being prepared, the deadline has lapsed and the deemed supply has kicked in. The right control is a continuous aging monitor with escalation triggers at 9-month, 10-month and 11-month ages so the loan-licensee return-workflow team pursues each pending challan with sufficient lead time — this is the trust-stack framing that Terra Insight’s Detection Envelope for human errors treats as an aging-and-timing control class distinct from the transaction-level reconciliation control class.

• ITC-04 portal-vs-books tie-out failure. After the quarterly ITC-04 is filed on the portal, the portal-acknowledged Table 4/5A/5B/6 summary counts and values must reconcile to the internal Rule 45 challan register aggregated for the quarter. Where the tie-out step is skipped (a common brand-owner shortcut where the ITC-04 preparer treats the filing as terminal), a dispatch challan omitted from Table 4 or a return challan double-counted in Table 5A goes undetected until a Section 65 audit surfaces it 18 months later — by which point the correction window has narrowed and interest exposure has compounded. Reconciliation discipline: the portal-vs-books tie-out is a defined post-filing step in the quarterly close calendar, with a variance log that any non-zero difference must trigger before Q+1 begins.

• Job-work service invoice IGST rate error — 18 percent instead of 12 percent for pharma. The loan-licensee’s HSN 9988 job-work service invoice attracts 12 percent GST for pharmaceutical job-work under the current CGST rate notification schedule. Loan-licensees whose invoicing system defaults to 18 percent GST for services (the general services rate for many categories) over-charge GST on the pharma-specific job-work supply; the brand-owner over-books ITC in its electronic credit ledger, and the loan-licensee over-pays GST to the government. Reconciliation discipline: the brand-owner’s GSTR-2B match step against each loan-licensee’s invoice must validate not just the invoice value and GSTIN but the HSN 9988 classification and the 12 percent rate; any 18 percent invoice must trigger a credit-note-and-reissue cycle with the loan-licensee before the ITC posts to the brand-owner’s ledger. The API contract manufacturing margin reconciliation for a CDMO walkthrough covers the parallel margin-and-rate reconciliation for the API-side contract-manufacturing engagement that some brand-owners run in addition to the formulation loan-licensee arrangement.

How a reconciliation platform handles this

A purpose-built pharma reconciliation platform ingests the brand-owner’s ERP dispatch feed (SAP FI material issue, Oracle Fusion inventory issue, or Tally material out), the loan-licensee return-challan intake (typically shared as a per-batch dispatch acknowledgement), and the brand-owner’s GSTR-2B auto-populated ITC statement for the loan-licensee HSN 9988 job-work service invoices — and maintains a per-challan Rule 45 material movement register that ties each dispatch to its expected 12-month return deadline, tracks the actual return against the deadline, aggregates the quarter’s movement into a Form GST ITC-04 draft with Tables 4, 5A, 5B and 6 correctly populated, runs the portal-vs-books tie-out after each quarterly filing, and drives a proactive aging monitor with escalation triggers at 9-month, 10-month and 11-month ages so pending returns can be pursued or the Rule 45(4) deemed-supply liability can be provisioned in the monthly close before the deadline lapses. Match rate improvement of 51 to 88 percent on the dispatch-to-return challan reconciliation and on the loan-licensee invoice to GSTR-2B match, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what makes the platform an infrastructure investment for a Tier 2 pharma brand-owner running a multi-state loan-licensee network rather than a spreadsheet substitute.

Cross-cluster bridges and where to read next

The Rule 45 material movement plus quarterly ITC-04 filing cycle documented in this article sits inside the broader loan-licensing manufacturing control framework — the commercial contract, drug licence, and CDMO margin economics of the pharma brand-owner-to-loan-licensee relationship are unpacked in the loan-licensing manufacturing and pharma CDMO reconciliation guide Wave 1 cornerstone. The API-side reconciliation for CDMOs that engage in bulk drug contract manufacturing (as distinct from formulation loan-licensing) is unpacked in the API contract manufacturing margin reconciliation for a CDMO walkthrough. The HSN classification interface between API dispatch (Chapter 29 or Chapter 30 bulk drug 3003) and finished formulation return (Chapter 30 formulation 3004) that the Rule 45 challan must correctly reflect on both dispatch and return legs is unpacked in the API vs formulation HSN 2941 / 3003 / 3004 reconciliation guide. The backward-integration transfer-pricing framework for brand-owners with their own API subsidiary that supplies to their own formulation loan-licensee arrangement — a Section 92BA specified-domestic-transaction scenario overlaid on the Section 143 job-work movement — is covered in the backward integration API manufacturing transfer pricing for pharma walkthrough.

The methodology framework for structuring the Rule 45 challan register, the ITC-04 portal-vs-books tie-out, and the 12-month aging monitor as a controlled reconciliation surface sits in Terra Insight’s own reconciliation failure mode analysis pillar and the reconciliation playbook monthly close operations pillar. The 12-month aging blind spot as a specific human-error control class — where the transaction itself is complete but the calendar clock enforces a downstream consequence — sits in the Detection Envelope for human errors trust-stack framing that pairs with the transaction-level reconciliation controls. The commercial pillar for the pharma sub-cluster is Pharma reconciliation software India; the broader authority is reconciliation software India with the GST reconciliation software surface for the ITC-04 quarterly return and Section 143 job-work compliance workflow.

The five FAQs below address the operational questions pharma indirect-tax leads, loan-licensee-management controllers and CDMO-relationship finance leads ask most often when running the quarterly Rule 45 to ITC-04 reconciliation across a multi-state loan-licensee network.

Terra Insight Editorial Team Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 16 July 2026

Domain expertise

TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops

Reviewed by

NK

Navin Krishnan

Managing Director & Founder — Terra Insight

Ex Amazon India · Intuit QuickBooks · Tata nexarc

ISO 27001:2022 Patent Pending Incorporated 2024